France's confidence in the AstraZeneca vaccine is astonishingly low


The public's confidence in AstraZeneca and Oxford University's COVID-19 vaccine is down noticeably in Europe and especially in France, a new poll has found — just as a large U.S. trial shows it to be 79 percent effective.
YouGov found in a new poll that in France, Germany, Spain, and Italy, "people are more likely to see the vaccine as unsafe than safe" after the vaccine's use was briefly paused there. This was particularly notable in France, where 61 percent of those surveyed said they think the vaccine is unsafe, up from 43 percent last month. In fact, just 23 percent of respondents in France said they believe the vaccine is safe. YouGov notes that even in February, though, more people in France thought the vaccine was unsafe than thought it was safe.
Meanwhile, 55 percent of respondents in Germany said they think the AstraZeneca vaccine is unsafe, and that number was 52 percent in Spain and 43 percent in Italy.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Use of the AstraZeneca vaccine was briefly paused in Europe amid concerns over whether it could be linked to blood clots, but it has since resumed, as the European Medicines Agency confirmed the vaccine to be safe and effective and found no increased blood clot risk. British Prime Minister Boris Johnson subsequently received a dose of the AstraZeneca vaccine and encouraged the public to do so as well.
According to YouGov, "only in Britain can the blood clots story be considered to have little to no impact," as the majority there continued to say they believe the vaccine to be safe. But elsewhere, YouGov writes, the decision to pause the vaccine's use in Europe "hugely damaged public perceptions of the vaccine's safety," with lead data journalist Matt Smith saying it has "undoubtedly suffered damage to its reputation for safety on the continent."
YouGov's poll was conducted by speaking to a group of roughly 8,000 people in seven countries from March 12 through March 18, according to Reuters. Read more at YouGov.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Jack Draper: can Britain's Wimbledon hopeful unseat Carlos Alcaraz?
In the Spotlight 'Volcano of emotion' smashes his racket during defeat in Queen's semi-final but world No.4 shows 'fighting spirit'
-
Crossword: June 23, 2025
The Week's daily crossword
-
How far would Russia go for Iran?
Today's Big Question US air strikes represent an 'embarrassment, provocation and opportunity' all rolled into one for Vladimir Putin
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments